Unknown

Dataset Information

The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy.


ABSTRACT: Immunotherapy has revolutionised cancer treatment. However, not all cancer patients benefit, and current stratification strategies based primarily on PD1 status and mutation burden are far from perfect. We hypothesised that high activation of an innate response relative to the adaptive response may prevent proper tumour neoantigen identification and decrease the specific anticancer response, both in the presence and absence of immunotherapy. To investigate this, we obtained transcriptomic data from three large publicly available cancer datasets, the Cancer Genome Atlas (TCGA), the Hartwig Medical Foundation (HMF), and a recently published cohort of metastatic bladder cancer patients treated with immunotherapy. To analyse immune infiltration into bulk tumours, we developed an RNAseq-based m

SUBMITTER: Ahrenfeldt J 

PROVIDER: S-EPMC9901741 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature